Business
Settlement with former United executive moves forward
NEWS IN BRIEF — Posted Sept. 1, 2008
It looks increasingly likely that former UnitedHealth Group CEO and Chair William McGuire, MD, will be held to his settlement terms regarding an investigation into his receiving improperly backdated stock options.
The Minnesota Supreme Court on Aug. 14 said that U.S. District Judge James Rosenbaum in Minneapolis had little leeway or standing to review a $420 million settlement Dr. McGuire reached to settle shareholder and Securities and Exchange Commission lawsuits regarding his stock options.
Dr. McGuire did not admit to wrongdoing in receiving options that the plaintiffs said were improperly dated to the lowest 52-week price of the stock, rather than the day they were issued.
Rosenbaum asked the state Supreme Court to give him guidance on reviewing the December 2007 settlement. Specifically, he wanted to know whether he must defer to a special litigation committee United set up to review shareholder claims.
The state Supreme Court said, under state law, Rosenbaum must, if it is clear the committee's members are independent and impartial. Rosenbaum still could decide whether the United committee meets that criteria.
But experts say that with two former Minnesota Supreme Court judges on the committee, it is unlikely Rosenbaum will decide it does not, which means the settlement may be finalized.
United and present and former executives have settled with shareholders or given back stock options under review. The latest settlement was a $900 million deal with shareholders in July, the largest backdating deal recorded.
Dr. McGuire gave back $200 million in options upon his ouster in late 2006, on top of the $420 million settlement under review. At their peak, his options were reportedly worth $1.8 billion.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2008/09/01/bibf0901.htm.












